M6620 (VX-970) in Selected Solid Tumors

Study Overview

This research study is studying a drug called M6620 as a possible treatment for advanced solid tumor.

Study Description

A Phase II Study of M6620 (VX-970) in Selected Solid Tumors

  • ClinicalTrials.gov Identifier: NCT03718091
  • Protocol Number: 18-274
  • Principal Investigator: Andrea Bullock

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

If you need assistance finding a study or if you have any questions, call us at 617-667-7000